Nkarta, Inc. is a clinical-stage biotechnology company that is focused on developing and commercializing cell therapies for the treatment of cancer. The company's proprietary platform technology, called Nkarta NKT cell therapy, is designed to harness the power of natural killer (NK) cells to target and kill cancer cells. Nkarta, Inc. is committed to advancing the field of cell therapy and improving the lives of patients with cancer. The company's mission is to develop safe and effective treatments that can cure cancer and improve patient outcomes.